News > Pfizer-BioNTech's Covid-19 vaccine may get full approval in US next week

Pfizer-BioNTech's Covid-19 vaccine may get full approval in US next week

Pfizer-BioNTech's two-dose vaccine against the coronavirus disease (Covid-19) is poised for full approval by the United States Food and Drug Administration (FDA) early next week.

The Pfizer-BioNTech Covid-19 vaccine, sold under the brand name Comirnaty, is expected to get full approval from the US FDA by Monday or Tuesday. The vaccine is currently being administered in the US on an emergency use approval (EUA) license.